Mackenzie Tatananni
Mackenzie Tatananni is a reporter at Barron's covering breaking financial news with a focus on markets, quantum computing, insider trading, and healthcare. Her coverage stands out for treating frontier technologies and insider activity as concrete market drivers, translating complex corporate moves and analyst research into clear explanations of why stocks move. She writes fast-turn news pieces, deeper features, and a recurring insider trading column that together give readers a continuous view of how new technologies, executive decisions, and regulatory shifts ripple through the market.
Quantum computing and frontier technology stocks
Quantum computing is a central pillar of Tatananni’s beat, and much of her work follows listed quantum companies as they evolve from speculative stories into investable businesses.
She has examined IBM’s quantum division as a potential reason to own the stock despite broader earnings pressure, framing the technology as a strategic asset within a legacy company. Her coverage of D-Wave Quantum tracks the company’s success in securing a National Science Foundation grant and highlights how government support intersects with investor sentiment.
She follows IonQ closely, including detailed takeaways from its investor day that cover a new quantum system, acquisition-driven expansion, and upgraded financial guidance. Her reporting on Pasqal’s planned listing on Nasdaq focuses on its positioning as a major new quantum bet for public markets. She also profiles momentum across the sector more broadly, writing on how analyst enthusiasm for names such as IonQ and Xanadu is building into a sustained investment theme.
In pieces on the “next fire moment” for quantum computing, she connects BofA Securities’ research, investor education tools like a “quantum dictionary,” and the widening pool of investors willing to put money into the space. Across these stories, she consistently links technical progress, government endorsements, and analyst coverage back to valuations, stock moves, and the question of when quantum becomes a mainstream portfolio allocation.
Insider trading and market-moving stock activity
Tatananni’s work on insider trading and notable stock moves is another defining strand of her coverage. She oversees Inside Scoop, a weekly Barron's print column on insider trading, which systematically tracks executive and boardroom buying and selling. Her breaking news pieces highlight large, concentrated insider purchases such as GameStop CEO Ryan Cohen’s multimillion-dollar stock buying spree over successive weeks.
She has reported on Mark Zuckerberg’s sale of tens of millions of dollars of Meta Platforms stock, setting the transaction within a broader pattern of insider activity at the company.
In cryptocurrency-linked markets, she covers corporate decisions that shift long-held strategies, such as MicroStrategy’s move to sell a large portion of its Bitcoin holdings to fund dividends, reframing a “HODL” approach into a cash-return story. Her reporting on Circle Internet Group shows her attention to conflicting Wall Street calls, explaining how a sharp downgrade can overpower a fresh buy rating and pull the stock lower.
Her social presence reinforces this focus, describing her role as “news + quantum + insider trading” for Barron’s and pointing followers back to her in-depth interviews with quantum executives whose comments later surface in investor marketing and hearings. Taken together, her insider and trading coverage emphasizes not just the headlines but the mechanics of how large trades, downgrades, and strategic pivots show up in prices and volumes.
Healthcare, pharmaceuticals, and biotech deals
Healthcare and pharmaceuticals form a third strand of Tatananni’s market coverage, often at the intersection of earnings, pipelines, and major deals. She has covered a potential merger between Bristol Myers Squibb and AstraZeneca as a signal of a broader biotech M&A cycle, showing how one high-profile tie-up can open the floodgates for similar transactions. Her reporting on Johnson & Johnson’s financial chief highlights management’s “clear line of sight” to double-digit growth by 2030 and places that guidance within the company’s reinvention from consumer health toward pharmaceuticals and medical devices.
She follows weight-loss drug makers closely, chronicling how companies such as Eli Lilly extend their lead in the obesity market and how those moves show up in earnings and competitive positioning.
In pieces on Foghorn Therapeutics, she covers the fallout from Eli Lilly scrapping a cancer-drug partnership, including layoffs and the end of future collaborations, linking pipeline setbacks to workforce and valuation impacts. Her coverage of Novo Nordisk’s partnership with Anthropic examines how AI tools like large language models are being integrated into drug discovery, balancing concerns about AI risks with the strategic bet that the technology can accelerate pharmaceutical R&D. Across these articles, she treats drug data, partnership structures, and regulatory developments as drivers of long-term growth narratives that investors need to factor into health-care portfolios.
Earnings shocks, analyst calls, and corporate strategy
Beyond sector-specific beats, Tatananni regularly covers earnings surprises and analyst calls that trigger sharp market reactions across technology, consulting, consumer, and credit markets.
She has reported on Accenture’s worst single-day stock drop on record, tying the move to mixed quarterly results, tempered growth expectations, and the company’s heavy AI investments that some analysts see as draining resources from core IT services. Her work on IBM includes pieces where she explains how positive signals from Accenture’s earnings can provide a “much-needed boost” to IBM’s stock by easing fears around consulting demand in an AI-disrupted environment.
She writes on themes such as casual dining stocks having a strong year, breaking down what operational and macro factors make the trend investable. In credit markets, she has covered how SoftBank’s activities give the junk-bond market an AI-related lift, linking corporate financing decisions to shifts in high-yield sentiment. Her reporting on companies like Rocket Lab frames them as emerging competitors to incumbents such as SpaceX, showing how launch contracts and technological milestones translate into stock performance.
Housing-market pieces compare names like Lennar and D.R. Horton, focusing on why one builder’s shares are hit harder in a weak environment and what that says about segment exposure and balance-sheet strength.
Across these stories, she leans on analyst reports, guidance changes, and deal terms to explain both abrupt price moves and longer-term shifts in how investors value corporate strategies.
Across quantum computing, insider trading, healthcare, and broad earnings coverage, Tatananni’s work is distinguished by its concentration on market-moving signals and its effort to connect technical or regulatory detail back to stock behavior.
She writes in a clear, news-driven style that foregrounds valuations, guidance, and capital flows rather than abstract themes. Her beat sits at the point where emerging technologies, executive decisions, and capital markets meet, and her reporting is built to show how that intersection shapes opportunities and risks for investors day by day.
4 more finance journalists.
Abigail Summerville
Abigail Summerville brings a leveraged finance background to her work covering consumer and retail mergers and acquisitions for Reuters. She reports on deal-making and capital markets across food, beverages, spirits, personal care, skincare, bath products and pet food. Her stories focus on transaction terms, ownership stakes, valuation, debt structures and funding sources. She often breaks news on potential sales and strategic reviews before formal announcements. Notable coverage includes Sazerac’s acquisition of Au Vodka, Blackstone’s exploration of a ZO Skin Health sale, CVC’s efforts to sell the parent of Dr Teal’s, and Colgate-Palmolive’s planned divestitures. She also covers consumer IPOs, including Jersey Mike’s and Black Rock Coffee, and co-writes Wall Street market reports. She joined Reuters in 2022 after three years covering leveraged finance and primary debt markets.
Adekunle Agbetiloye
Adekunle Agbetiloye is a senior reporter who connects capital flows, hard numbers and energy transition to the wider African economy. He works at Business Insider Africa, covering how money, technology and energy reshape economic growth, jobs and living conditions. His beat spans the African economy, technology, energy transition, climate change, startups and critical minerals, with a focus on concrete deals and data-led stories. He reports on African startup funding cycles, sovereign wealth funds, billionaire investors, multilateral and private investment programs, energy and power markets, Bitcoin mining, and economic policy choices. His work follows how governments finance spending, manage debt and respond to social pressure, and how sector snapshots and health and development metrics reveal links between macro indicators, corporate strategy and everyday costs.
Aimee Picchi
Aimee Picchi connects Social Security, retirement programs and economic policy directly to the financial security of ordinary Americans, showing how macro decisions hit household budgets. She is associate managing editor for CBS MoneyWatch at CBS News, covering business and personal finance with clear, accessible explanations of complex money issues. Her core beat is Social Security and retirement, interest rates and inflation, and how policy, markets and company strategies affect workers, retirees, savers and investors. She reports on benefit adequacy, looming Social Security cuts, COLA changes, Federal Reserve rate decisions, fuel costs, trade tensions and labor’s share of income, always framing coverage around pocketbook impacts. Her background includes retirement reporting fellowships, prior staff reporting on technology, media and business, an Institutional Investor book on affluent investors, and freelance work for national outlets. She also writes science fiction and fantasy and is a Nebula Award finalist.
Alex Harring
Alex Harring turns fast-moving market, economic and corporate developments into clear pre-market briefings that show what will matter when U.S. trading opens. He is a markets and economics reporter for CNBC’s digital platforms and writes Morning Squawk, a flagship daily newsletter that gives readers five key things to know before the stock market opens. His beat spans financial markets, investing, consumer trends and the U.S. economy, with coverage of central bank decisions, inflation, corporate strategy, sector moves and geopolitical shocks. He focuses on how policy, data and earnings shape equities, interest rates, currencies and investor positioning, linking price action with underlying drivers in real time and in reported features. Harring’s background reporting on corporate news, business and the economy across print, digital, broadcast and streaming informs his habit of connecting markets, companies and geopolitics in one frame.